Baxter International Inc. (BAX) Stock Forecast
BAX analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.21 / 5 from 14 analysts
- Price target
- $27.92 average of analyst targets
- Upside to target
- +10.4% from the latest close
- Next earnings
- October 29, 2026 EPS estimate $0.51
- 52-week range
- $15.80 – $28.35
BAX analyst ratings
14 analystsNumber of analysts at each rating.
BAX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
BAX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.52 | $0.50 | $0.54 | $0.69 | −24.9% | 12 |
| Current fiscal year (2026) | $2.05 | $1.97 | $2.09 | $2.27 | −9.9% | 14 |
| Next fiscal year (2027) | $2.04 | $1.94 | $2.12 | $2.05 | −0.3% | 14 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
BAX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.91B | $2.88B | $2.92B | +2.6% | 11 |
| Current fiscal year (2026) | $11.62B | $11.59B | $11.65B | +3.3% | 12 |
| Next fiscal year (2027) | $11.87B | $11.79B | $11.93B | +2.1% | 12 |
BAX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
BAX revenue: reported and forecast
BAX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.53 | $0.52 | $0.52 | $0.52 | $0.52 | −2.6% | 2 up · 7 down |
| Current fiscal year (2026) | $1.92 | $2.05 | $2.05 | $2.05 | $2.05 | +6.7% | 12 up · 0 down |
| Next fiscal year (2027) | $2.01 | $2.04 | $2.04 | $2.04 | $2.04 | +1.7% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
BAX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; BAX beat in 9 of 12.
What analysts expect from BAX
14 analysts cover Baxter; their consensus rating is hold (3.21 on a 1–5 scale, where 5 is a strong buy). The average price target is $27.92, 10.4% above the latest close of $25.28. Analysts expect earnings of $2.05 per share for 2026, −9.9% from a year earlier. For 2027 the average estimate is $2.04 per share on revenue of $11.9 billion. Baxter beat the EPS estimate in 9 of the last 12 quarters.
Related: BAX income statement, BAX key metrics, BAX chart. See the BAX stock overview for the latest quote and news.
BAX forecast FAQ
What is Baxter's price target?
The average analyst price target for Baxter is $27.92, 10.4% above the latest close of $25.28.
Is Baxter a buy, hold or sell?
Of 14 analysts covering Baxter, 2 rate it a strong buy, 0 a buy, 11 a hold, 1 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Baxter's EPS forecast?
Analysts forecast $2.05 per share for 2026 (range $1.97 to $2.09); for 2027 the estimate is $2.04.
What is Baxter's revenue forecast?
The average revenue estimate for 2026 is $11.6 billion, growth of 3.3%; for 2027 it is $11.9 billion.
When does Baxter report earnings?
Baxter is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 before the market opens; the EPS estimate is $0.51.
Does Baxter usually beat earnings estimates?
Baxter reported EPS at or above the analyst estimate in 9 of the last 12 quarters.